ELVN Smart Money
Enliven Therapeutics, Inc.
1W: +5.9%
1M: -5.0%
3M: -17.5%
YTD: +181.2%
1Y: +112.0%
3Y: +245.4%
5Y: +193.6%
$43.69
+2.20 (+5.30%)
Pre-Market: $40.81 (-2.88, -6.58%)
Weekly Expected Move ±6.8%
$36
$39
$42
$44
$47
Credit Risk of going bust: lower than 83% of companies Debt: 0.0% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.00 (down more than 99.9%), Enliven Therapeutics, Inc. would be worth roughly what it owes.
Total debt $1.5M against a stock market value of $3.20B.
Distance to default 10.64 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $1.1M (short-term plus half of long-term), stock volatility 73.3%; Altman Z'' 66.56. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.00 (down more than 99.9%), Enliven Therapeutics, Inc. would be worth roughly what it owes.
Total debt $1.5M against a stock market value of $3.20B.
Distance to default 10.64 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $1.1M (short-term plus half of long-term), stock volatility 73.3%; Altman Z'' 66.56. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026234
Institutions Holding
+46 vs prior
122.3%
Ownership
+46.65%
68
New
86
Increased
65
Reduced
18
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-19 | Collins Helen Louise | officer: chief medical officer | S-Sale | 5,000 | $38.47 | $192K | Filing |
| 2026-10-19 | Hohl Benjamin | officer: chief financial officer | S-Sale | 6,018 | $38.48 | $232K | Filing |
| 2026-10-01 | Garland J. Scott | director | S-Sale | 13,000 | $46.67 | $607K | Filing |
| 2026-09-17 | Collins Helen Louise | officer: chief medical officer | S-Sale | 240 | $51.48 | $12K | Filing |
| 2026-09-17 | Collins Helen Louise | officer: chief medical officer | S-Sale | 1,844 | $50.71 | $94K | Filing |
| 2026-09-17 | Collins Helen Louise | officer: chief medical officer | S-Sale | 2,916 | $50.03 | $146K | Filing |
| 2026-09-17 | Hohl Benjamin | officer: chief financial officer | S-Sale | 289 | $51.49 | $15K | Filing |
| 2026-09-17 | Hohl Benjamin | officer: chief financial officer | S-Sale | 2,194 | $50.72 | $111K | Filing |
| 2026-09-17 | Hohl Benjamin | officer: chief financial officer | S-Sale | 3,535 | $50.03 | $177K | Filing |
| 2026-08-17 | Hohl Benjamin | officer: chief financial officer | S-Sale | 1,388 | $59.35 | $82K | Filing |
| 2026-08-17 | Hohl Benjamin | officer: chief financial officer | S-Sale | 4,630 | $58.35 | $270K | Filing |
| 2026-08-17 | Collins Helen Louise | officer: chief medical officer | S-Sale | 3,900 | $58.37 | $228K | Filing |
| 2026-08-17 | Collins Helen Louise | officer: chief medical officer | S-Sale | 1,100 | $59.35 | $65K | Filing |
| 2026-08-04 | Derynck Mika K | director | S-Sale | 158,795 | $60.21 | $9.6M | Filing |
| 2026-07-17 | Hohl Benjamin | officer: chief financial officer | S-Sale | 2,564 | $52.32 | $134K | Filing |
| 2026-07-17 | Collins Helen Louise | officer: chief medical officer | S-Sale | 63 | $53.92 | $3K | Filing |
| 2026-07-17 | Collins Helen Louise | officer: chief medical officer | S-Sale | 2,184 | $53.42 | $117K | Filing |
| 2026-07-17 | Collins Helen Louise | officer: chief medical officer | S-Sale | 2,063 | $52.39 | $108K | Filing |
| 2026-07-17 | Collins Helen Louise | officer: chief medical officer | S-Sale | 459 | $51.55 | $24K | Filing |
| 2026-07-17 | Collins Helen Louise | officer: chief medical officer | S-Sale | 231 | $50.05 | $12K | Filing |
| 2026-07-17 | Hohl Benjamin | officer: chief financial officer | S-Sale | 123 | $53.87 | $7K | Filing |
| 2026-07-17 | Hohl Benjamin | officer: chief financial officer | S-Sale | 2,638 | $53.38 | $141K | Filing |
| 2026-07-17 | Hohl Benjamin | officer: chief financial officer | S-Sale | 369 | $51.48 | $19K | Filing |
| 2026-07-17 | Hohl Benjamin | officer: chief financial officer | S-Sale | 324 | $49.97 | $16K | Filing |
| 2026-07-06 | Kunkel Lori Anne | director | S-Sale | 5,889 | $50.84 | $299K | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| FMR LLC | 10,025,017 | $509M | +3,195,771 | 2026-06-30 | Filing |
| ORBIMED ADVISORS LLC | 6,776,632 | $344M | -1,182,906 | 2026-06-30 | Filing |
| Polar Capital Holdings Plc | 6,430,636 | $326M | +1,364,703 | 2026-06-30 | Filing |
| BlackRock, Inc. | 4,359,704 | $221M | +674,997 | 2026-06-30 | Filing |
| Vestal Point Capital, LP | 4,000,000 | $203M | +750,000 | 2026-06-30 | Filing |
| Commodore Capital LP | 3,275,000 | $166M | — | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 2,569,002 | $130M | +400,840 | 2026-06-30 | Filing |
| CITADEL ADVISORS LLC | 2,068,992 | $105M | +325,077 | 2026-06-30 | Filing |
| Fairmount Funds Management LLC | 1,855,644 | $94M | — | 2026-06-30 | Filing |
| Siren, L.L.C. | 1,774,411 | $90M | +1,028,185 | 2026-06-30 | Filing |
| Bellevue Group AG | 1,490,000 | $76M | -830,867 | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 1,407,202 | $71M | +340,782 | 2026-06-30 | Filing |
| First Light Asset Management, LLC | 1,360,750 | $69M | +1,158,883 | 2026-06-30 | Filing |
| STATE STREET CORP | 1,213,616 | $62M | +122,510 | 2026-06-30 | Filing |
| Pictet Asset Management Holding SA | 1,161,784 | $59M | +232,240 | 2026-06-30 | Filing |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,083,313 | $55M | +1,083,313 | 2026-06-30 | Filing |
| NOVO HOLDINGS A/S | 1,000,000 | $51M | -280,000 | 2026-06-30 | Filing |
| First Turn Management, LLC | 954,360 | $48M | +330,521 | 2026-06-30 | Filing |
| SAMLYN CAPITAL, LLC | 912,637 | $46M | +912,637 | 2026-06-30 | Filing |
| BAKER BROS. ADVISORS LP | 905,191 | $46M | — | 2026-06-30 | Filing |